Recent advances in biosensor devices for HER-2 cancer biomarker detection. Issue 13 (23rd March 2022)

• Record Type: Journal Article
• Authors: Chupradit, Supat; Jasim, Saade Abdalkareem; Bokov, Dmitry; Mahmoud, Mustafa Z.; Roomi, Ali B.; Hachem, Kadda; Rudiansyah, Mohammad; Suksatan, Wanich; Bidares, Ramtin
• Is Part Of: Analytical methods. Volume 14:Issue 13(2022)
• Page Start: 1301
• Page End: 1310
• Publication Date: 2022-03-23
• Subjects: Chemistry, Analytic -- Periodicals; Analytical biochemistry -- Periodicals; Chemical laboratories -- Standards -- Periodicals; 543.1905
• DOI: 10.1039/d2ay00111j
• Languages: English
• ISSNs: 1759-9660

Abstract

Abstract : The human epidermal growth factor receptor 2 (HER-2) protein is a member of the epidermal growth factor receptor (EGFR or ErbB) family and is a transmembrane tyrosine kinase receptor. Abstract : The human epidermal growth factor receptor 2 (HER-2) protein is a member of the epidermal growth factor receptor (EGFR or ErbB) family and is a transmembrane tyrosine kinase receptor. HER-2 is highly regulated in ovarian, lung, gastric, oral, and breast cancers. The low specificity, complexity, expensiveness and the lack of sensitivity are essential restrictions in traditional diagnosis methods such as FISH, immunohistochemistry and PCR and these disadvantages led to the need for more studies on alternative methods. Biosensor technology has greatly affected the quality of human life owing to its features including, sensitivity, specificity, and rapid diagnosis and monitoring of different patient diseases. In this review article, we examine various biosensors, considering that they have been categorized based on the transducers used including piezoelectric biosensors, optical sensors such as fluorescence and surface plasmon resonance, and electrochemical types for the diagnosis of HER-2 and the effectiveness of some drugs against that. Attention to developing some types of biosensor devices such as colorimetric biosensors for HER-2 detection can be an important point in future studies.